These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24594379)

  • 21. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.
    Fatterpekar GM; Galheigo D; Narayana A; Johnson G; Knopp E
    AJR Am J Roentgenol; 2012 Jan; 198(1):19-26. PubMed ID: 22194475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project.
    Direksunthorn T; Chawalparit O; Sangruchi T; Witthiwej T; Tritrakarn SO; Piyapittayanan S; Charnchaowanish P; Pornpunyawut P; Sathornsumetee S
    J Med Assoc Thai; 2013 Sep; 96(9):1183-90. PubMed ID: 24163995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
    Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
    Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma.
    Roy B; Awasthi R; Bindal A; Sahoo P; Kumar R; Behari S; Ojha BK; Husain N; Pandey CM; Rathore RK; Gupta RK
    J Comput Assist Tomogr; 2013; 37(3):321-6. PubMed ID: 23673999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them?
    Bisdas S; Braun C; Skardelly M; Schittenhelm J; Teo TH; Thng CH; Klose U; Koh TS
    NMR Biomed; 2014 Oct; 27(10):1184-91. PubMed ID: 25088433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI.
    Hakyemez B; Erdogan C; Gokalp G; Dusak A; Parlak M
    Clin Radiol; 2010 Jan; 65(1):15-20. PubMed ID: 20103416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
    Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
    Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
    Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
    Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume.
    Kim HR; Kim SH; Lee JI; Seol HJ; Nam DH; Kim ST; Park K; Kim JH; Kong DS
    J Neurooncol; 2015 Jan; 121(2):311-8. PubMed ID: 25488072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
    Boxerman JL; Ellingson BM; Jeyapalan S; Elinzano H; Harris RJ; Rogg JM; Pope WB; Safran H
    Am J Clin Oncol; 2017 Jun; 40(3):228-234. PubMed ID: 25436828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic contrast-enhanced MR perfusion imaging of head and neck tumors at 3 Tesla.
    Furukawa M; Parvathaneni U; Maravilla K; Richards TL; Anzai Y
    Head Neck; 2013 Jul; 35(7):923-9. PubMed ID: 22887003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinction between postoperative recurrent glioma and delayed radiation injury using MR perfusion weighted imaging.
    Xu JL; Shi DP; Dou SW; Li YL; Yan FS
    J Med Imaging Radiat Oncol; 2011 Dec; 55(6):587-94. PubMed ID: 22141606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients.
    Bendini M; Marton E; Feletti A; Rossi S; Curtolo S; Inches I; Ronzon M; Longatti P; Di Paola F
    Acta Neurochir (Wien); 2011 Feb; 153(2):403-12. PubMed ID: 21165751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.
    Kang KM; Choi SH; Chul-Kee P; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Yun TJ; Kim JH; Sohn CH
    Eur Radiol; 2021 Dec; 31(12):9098-9109. PubMed ID: 34003350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
    Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
    Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging.
    Jia Z; Geng D; Xie T; Zhang J; Liu Y
    J Clin Neurosci; 2012 Jun; 19(6):820-3. PubMed ID: 22381582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R; Babb J; Law M; Pollack E; Johnson G
    J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.
    Conte GM; Altabella L; Castellano A; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Caulo M; Falini A; Anzalone N
    Eur Radiol; 2019 Jul; 29(7):3467-3479. PubMed ID: 30972545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging.
    Cha J; Kim ST; Nam DH; Kong DS; Kim HJ; Kim YK; Kim HY; Park GM; Jeon P; Kim KH; Byun HS
    Clin Neuroradiol; 2017 Sep; 27(3):329-334. PubMed ID: 26952018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.